Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial

Abstract Background Based on promising results from a Phase I study of hepatic arterial infusion chemotherapy using a combination of miriplatin and cisplatin powder (DDP-H) for unresectable hepatocellular carcinoma (UMIN-CTR000003541), a multicenter, open-label, randomized phase II study was conduct...

Full description

Bibliographic Details
Main Authors: Kenya Kamimura, Takeshi Suda, Takeshi Yokoo, Hiroteru Kamimura, Tsutomu Kanefuji, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Nobuo Waguri, Satoshi Yamagiwa, Shuji Terai
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Interventional radiology
Miriplatin
Cisplatin powder
Phase II clinical trial
Online Access:http://link.springer.com/article/10.1186/s12885-017-3320-7

Internet

http://link.springer.com/article/10.1186/s12885-017-3320-7

Similar Items